The U.S. Justice Department said on Monday that American Airlines Group made $425 million by selling take-off and landing slots at two busy East Coast airports, as required to win approval for the merger that set up the company. American Airlines Group Inc. (NASDAQ:AAL) stock performance was -0.15% in last session and finished the day…
CRT Capital Thursday morning ratings report included a coverage initiation by analyst Arlinda Lee on Oncogenex Pharmaceuticals (NASDAQ: OGXI) with a Buy rating and price target of $20. OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) rose 8.88 percent to $13.85 yesterday on volume of 483,342million shares. The intra-day range of the stock was $12.61 to $13.95. OncoGenex Pharmaceuticals…
German health regulators have granted Northwest Biotherapeutics Inc (NASDAQ:NWBO) special permission to sell its experimental brain cancer drug, DCVax-L, in the country, even though the small US biotechnology company has not yet completed its late-stage trial of the immunotherapy. Northwest Biotherapeutics, Inc (NASDAQ:NWBO) stock performance was 29.55% in last session and finished the day at…
Health Net (NYSE:HNT), a managed care company, disclosed in a regulatory filing Monday that it will be reaffirming its earnings guidance for fiscal 2014 at the Barclays Global Healthcare Conference on Tuesday. The company had previously said that it is expecting fiscal 2014 earnings of at least $3.00 per share and revenue of $14.4 billion….
Boyd Gaming (NYSE:BYD) is surging in after-hours trading after activist hedge fund Elliott Associates disclosed a stake in the casino operator. In a filing with the SEC, Elliott disclosed it owns 4.99% of Boyd’s outstanding common stock, with a 2.05% exposure to common shares via derivatives. Elliott said its combined economic exposure to Boyd (NYSE:BYD)…
Kythera (NASDAQ:KYTH) and Bayer ADR (OTCMRKTS:BAYRY) announced that Kythera acquired all rights outside of the U.S. and Canada to ATX-101, a proprietary formulation of a purified synthetic version of deoxycholic acid currently in late-stage development for the reduction of submental fat (double chin). In 2010, KYTHERA (NASDAQ:KYTH) licensed the commercial rights to ATX-101 outside of…
Tech Analysis & Market News